BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

508 related articles for article (PubMed ID: 30799057)

  • 21. Global regulation of alternative RNA splicing by the SR-rich protein RBM39.
    Mai S; Qu X; Li P; Ma Q; Cao C; Liu X
    Biochim Biophys Acta; 2016 Aug; 1859(8):1014-24. PubMed ID: 27354116
    [TBL] [Abstract][Full Text] [Related]  

  • 22. No Matter How You Splice It, RBM39 Inhibition Targets Spliceosome Mutant AML.
    Thomas R; Majeti R
    Cancer Cell; 2019 Mar; 35(3):337-339. PubMed ID: 30889374
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A SALL4/MLL/HOXA9 pathway in murine and human myeloid leukemogenesis.
    Li A; Yang Y; Gao C; Lu J; Jeong HW; Liu BH; Tang P; Yao X; Neuberg D; Huang G; Tenen DG; Chai L
    J Clin Invest; 2013 Oct; 123(10):4195-207. PubMed ID: 24051379
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TF-RBP-AS Triplet Analysis Reveals the Mechanisms of Aberrant Alternative Splicing Events in Kidney Cancer: Implications for Their Possible Clinical Use as Prognostic and Therapeutic Biomarkers.
    He M; Hu F
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445498
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Loss of RNA-binding protein CELF2 promotes acute leukemia development via FAT10-mTORC1.
    Guo T; Wang Y; Sun X; Hou S; Lan Y; Yuan S; Yang S; Zhao F; Chu Y; Ma Y; Cheng T; Yu J; Liu B; Yuan W; Wang X
    Oncogene; 2024 May; 43(19):1476-1487. PubMed ID: 38514854
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-708 is a novel regulator of the Hoxa9 program in myeloid cells.
    Schneider E; Pochert N; Ruess C; MacPhee L; Escano L; Miller C; Krowiorz K; Delsing Malmberg E; Heravi-Moussavi A; Lorzadeh A; Ashouri A; Grasedieck S; Sperb N; Kumar Kopparapu P; Iben S; Staffas A; Xiang P; Rösler R; Kanduri M; Larsson E; Fogelstrand L; Döhner H; Döhner K; Wiese S; Hirst M; Keith Humphries R; Palmqvist L; Kuchenbauer F; Rouhi A
    Leukemia; 2020 May; 34(5):1253-1265. PubMed ID: 31768018
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Emerging Multi-cancer Regulatory Role of ESRP1: Orchestration of Alternative Splicing to Control EMT.
    Vadlamudi Y; Dey DK; Kang SC
    Curr Cancer Drug Targets; 2020; 20(9):654-665. PubMed ID: 32564755
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of circRNA-lncRNA-miRNA-mRNA Competitive Endogenous RNA Network as Novel Prognostic Markers for Acute Myeloid Leukemia.
    Cheng Y; Su Y; Wang S; Liu Y; Jin L; Wan Q; Liu Y; Li C; Sang X; Yang L; Liu C; Wang Z
    Genes (Basel); 2020 Jul; 11(8):. PubMed ID: 32751923
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Exploration of novel therapeutic targets in acute myeloid leukemia via genome-wide CRISPR screening].
    Yamauchi T
    Rinsho Ketsueki; 2019; 60(7):810-817. PubMed ID: 31391371
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exosomes Secreted by Apoptosis-Resistant Acute Myeloid Leukemia (AML) Blasts Harbor Regulatory Network Proteins Potentially Involved in Antagonism of Apoptosis.
    Wojtuszkiewicz A; Schuurhuis GJ; Kessler FL; Piersma SR; Knol JC; Pham TV; Jansen G; Musters RJ; van Meerloo J; Assaraf YG; Kaspers GJ; Zweegman S; Cloos J; Jimenez CR
    Mol Cell Proteomics; 2016 Apr; 15(4):1281-98. PubMed ID: 26801919
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LEDGF/p75 has increased expression in blasts from chemotherapy-resistant human acute myelogenic leukemia patients and protects leukemia cells from apoptosis in vitro.
    Huang TS; Myklebust LM; Kjarland E; Gjertsen BT; Pendino F; Bruserud Ø; Døskeland SO; Lillehaug JR
    Mol Cancer; 2007 Apr; 6():31. PubMed ID: 17451600
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevated SH3BP5 Correlates with Poor Outcome and Contributes to the Growth of Acute Myeloid Leukemia Cells.
    Li M; Hao S; Li C; Xiao H; Sun L; Yu Z; Zhang N; Xiong Y; Zhao D; Yin Y
    Biomolecules; 2019 Sep; 9(9):. PubMed ID: 31546831
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting Chromatin Regulators Inhibits Leukemogenic Gene Expression in NPM1 Mutant Leukemia.
    Kühn MW; Song E; Feng Z; Sinha A; Chen CW; Deshpande AJ; Cusan M; Farnoud N; Mupo A; Grove C; Koche R; Bradner JE; de Stanchina E; Vassiliou GS; Hoshii T; Armstrong SA
    Cancer Discov; 2016 Oct; 6(10):1166-1181. PubMed ID: 27535106
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long Non-Coding RNA Expression Levels Modulate Cell-Type-Specific Splicing Patterns by Altering Their Interaction Landscape with RNA-Binding Proteins.
    Porto FW; Daulatabad SV; Janga SC
    Genes (Basel); 2019 Aug; 10(8):. PubMed ID: 31390792
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transcription factor AP-2α regulates acute myeloid leukemia cell proliferation by influencing Hoxa gene expression.
    Ding X; Yang Z; Zhou F; Wang F; Li X; Chen C; Li X; Hu X; Xiang S; Zhang J
    Int J Biochem Cell Biol; 2013 Aug; 45(8):1647-56. PubMed ID: 23660297
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Focused CRISPR-Cas9 genetic screening reveals USO1 as a vulnerability in B-cell acute lymphoblastic leukemia.
    Jaiswal AK; Truong H; Tran TM; Lin TL; Casero D; Alberti MO; Rao DS
    Sci Rep; 2021 Jun; 11(1):13158. PubMed ID: 34162911
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15.
    Han T; Goralski M; Gaskill N; Capota E; Kim J; Ting TC; Xie Y; Williams NS; Nijhawan D
    Science; 2017 Apr; 356(6336):. PubMed ID: 28302793
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IDH2 and NPM1 Mutations Cooperate to Activate Hoxa9/Meis1 and Hypoxia Pathways in Acute Myeloid Leukemia.
    Ogawara Y; Katsumoto T; Aikawa Y; Shima Y; Kagiyama Y; Soga T; Matsunaga H; Seki T; Araki K; Kitabayashi I
    Cancer Res; 2015 May; 75(10):2005-16. PubMed ID: 25795706
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circular RNA circ_0005774 contributes to proliferation and suppresses apoptosis of acute myeloid leukemia cells via circ_0005774/miR-192-5p/ULK1 ceRNA pathway.
    Li Q; Luan Q; Zhu H; Zhao Y; Ji J; Wu F; Yan J
    Biochem Biophys Res Commun; 2021 Apr; 551():78-85. PubMed ID: 33735626
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transcriptome Profiling of Pediatric Core Binding Factor AML.
    Hsu CH; Nguyen C; Yan C; Ries RE; Chen QR; Hu Y; Ostronoff F; Stirewalt DL; Komatsoulis G; Levy S; Meerzaman D; Meshinchi S
    PLoS One; 2015; 10(9):e0138782. PubMed ID: 26397705
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.